<DOC>
	<DOCNO>NCT00600392</DOCNO>
	<brief_summary>Genes express inflammatory cytokine ( TNF- alpha , IL1 etc ) gene involve apoptosis ( Caspase 3 , Bax , Bcl-2 , Fas ) dysregulated skeletal muscle patient muscle waste decrease exercise capacity CHF . Patients show benefit CRT may also show reversal inflammatory/apoptotic cascade accompanies CHF patient may one benefit CRT</brief_summary>
	<brief_title>DNA/RNA Analysis Blood Skeletal Muscle Patients Undergoing Cardiac Resynchronization Therapy ( CRT )</brief_title>
	<detailed_description>1 . The general objective study : 1 . To identify molecular pathway may alter blood skeletal muscle patient undergo CRT use transcriptional analysis blood skeletal muscle patient 2 . To identify objective measurable molecular signal , use gene expression profiling , correlate clinical improvement patient undergo CRT . 3 . To identify molecular profile patient likely benefit CRT improvement exercise capacity reversal cardiac cachexia . 4 . To identify biochemical pathway involve cardiac cachexia . 5 . To identify gene involve positive remodel reversal apoptotic cascade skeletal muscle .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Patients poor LV function EF â‰¤35 % Patients symptomatic Class II Class III heart failure optimal medical therapy . Patients EKG show QRS duration great 120 m meet criterion Biventricular ICD implantation . Patients comorbid condition could contribute cachexia , end stage renal disease , ongoing malignancy , chronic acute liver failure , age great 80yrs . Patients unable walk wheelchair bound need assistance walk reason CHF . Patients muscular dystrophy myopathy . Patients untreated hyper hypothyroidism . Patients Dialysis . Patients recent ( &lt; 12 week ) revascularization . Patients recent ( &lt; 12 week ) myocardial infarction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>